Evaluation Of Eslicarbazepine In The Management Of Partial Seizures

By Dixit Dirghayu

Eslicarbazepine is a novel adds on therapy introduced in Indian market in April 2011 in the management of partial seizures. Despite of having a strong pool of evidences & EMEA approval, this molecule in-clinic usage is not as per expectations. Through this research work, we intend to make an attempt to understand underlying psychological & environmental (peer group effect) factors restricting the potential of molecule. The major emphasize of my work was to "EVALUATION OF IN - CLINIC USAGE OF ESLICARBAZEPINE IN THE MANAGEMENT OF PARTIAL SEIZURES" This project gave me immense opportunities to upgrade my knowledge related to marketing field and also gave me a chance to learn and understand the strategies to be kept in mind while making a new molecule for AED's.

• Format: Paperback
• Language: English
• ISBN: 3659679623
• ISBN13: 9783659679629
• Release Date: February 2015
• Publisher: LAP Lambert Academic Publishing
• Length: 96 Pages
• Weight: 0.33 lbs.
• Dimensions: 0.2" x 6.0" x 9.0"